跳至主要内容
临床试验/NL-OMON53544
NL-OMON53544招募中不适用

MARS study- Mesh Augmented Reinforcement of Abdominal Wall Suture Line in Patients Undergoing Midline Laparotomy to limit the Rate of Incisional Hernia ( IH) Occurrence - MARS study

niversitair Medisch Centrum0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Preoperative Inclusion Criteria
  • 1. Subject has provided informed consent.
  • 2. Subject is >=18 years of age at the time of consent.
  • 3. Subject will be undergoing an elective surgery with a planned midline
  • laparotomy with retrorectus mesh placement.
  • 3A. Subject will be undergoing an elective laparoscopy with a planned
  • possibility of a conversion to midline laparotomy or an elective laparoscopy
  • with a planned possible midline laparotomy for specimen extraction.

排除标准

  • Preoperative Exclusion Criteria
  • 1. Subject is undergoing emergency surgery, i.e. lifesaving procedures
  • performed where patient is in imminent danger of death
  • 2. Subject has a history of allergic reactions after application of
  • poly-L-lactide, poly-trimethylene carbonate copolymers (PLLA/TMC)
  • 3. Subject is pregnant or is planning pregnancy during study duration
  • period(Females of child-bearing potential will be required to provide either a
  • urine or serum pregnancy test (except for subjects who are surgically sterile
  • or are at least 2 years post-menopausal))
  • 3a: Subject is breastfeeding or is planning to breastfeed during the study
  • duration period
  • 4. Subject is unable or unwilling to comply with the study requirements or
  • follow-up schedule
  • 5. Subject is scheduled for another planned surgery, and subsequent surgery
  • would jeopardize previous application of study treatment
  • 6. Subject with a body mass index (BMI) > 45 kg/m2
  • 7. Subjects with the following medical interventions/medical conditions are
  • excluded from participation in the study: uncontrolled diabetes (hemoglobin A1c
  • (Hb1Ac) > 60mmol/mol), cirrhosis, stoma wearers
  • 8. Concomitant ostomy (stomacreation)
  • 9. Subject who had received a mesh in a previous ventral hernia repair or has
  • an existing ventral hernia>2cm
  • 10. Subject with a life expectancy inferior to the study follow-up duration (36
  • 11. Study procedure is a relaparotomy within 30 days of previous abdominal
  • 12. Subject with an American Society of Anesthesiologists (ASA) scores higher
  • 13. Subject has participated in an investigational drug study within the
  • washout period of the drug or in a device study that would interfere with mesh
  • implantation or assessment of incisional hernia
  • 14. Subject with current chemo and/or radiation therapy within 2 weeks of
  • Only exclusion of chemotherapeutic drugs that have:
  • Cytotoxic effect and/or
  • Inhibit of cell replication and/or
  • Impaired tissue healing
  • 15. Subject with any history of ascites
  • 16. Subject has a medical condition that precludes the patient from
  • participation in the opinion of the investigator
  • 17. Subject is undergoing a vascular procedure other than abdominal aortic
  • aneurysm (AAA) surgery (i.e, only AAA surgeries accepted)
  • Intraoperative Exclusion criteria
  • 1. Subject*s study procedure is in a contaminated or infected site as assessed
  • by the Investigator(s) (CDC Class 3 and 4)
  • 2. Abdomen is left open at the end of the procedure
  • 3. Subject has an unsuspected ventral hernia >2cm encountered at the time of
  • 4. Inability to close the anterior fascia or keep the mesh securely out of the
  • peritoneal cavity
  • 5. Second-look procedure planned
  • 6. Cases requiring a full-thickness partial resection of the abdominal wall (in
  • particular the midline) because of involvement in neoplastic process or complex
  • 7. Inoperable tumor/poor prognostic cancer/patient non curatively treated
  • 8. Subject has a suture length to wound length ratio< 3.5/1
  • 另有 4 项未显示

研究者

发起方
niversitair Medisch Centrum

相似试验

MARS study- Mesh Augmented Reinforcement of... | 临床试验